NCT06678165View on ClinicalTrials.gov

A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Transfusion Dependent Beta Thalassemia
Interventions
DRUG

YOLT-204

The intervention group will receive YOLT-204 on day0

Trial Locations (1)

530000

The First Affiliated Hospital of Guangxi Medical University, Nanning

All Listed Sponsors
lead

First Affiliated Hospital of Guangxi Medical University

OTHER